Working… Menu

IDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients. (IDOvaccine)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01219348
Recruitment Status : Completed
First Posted : October 13, 2010
Last Update Posted : August 18, 2015
Information provided by (Responsible Party):
Inge Marie Svane, Herlev Hospital